Goldhirsch A - Search Results

1

A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients.

Biffi R, De Braud F, Orsi F, Pozzi S, Arnaldi P, Goldhirsch A, Rotmensz N, Robertson C, Bellomi M, Andreoni B. Biffi R, et al. Among authors: goldhirsch a. Cancer. 2001 Sep 1;92(5):1204-12. doi: 10.1002/1097-0142(20010901)92:5<1204::aid-cncr1439>3.0.co;2-9. Cancer. 2001. PMID: 11571734 Clinical Trial.

2

Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.

Biffi R, de Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsch A, Nolè F, Andreoni B. Biffi R, et al. Among authors: goldhirsch a. Ann Oncol. 1998 Jul;9(7):767-73. doi: 10.1023/a:1008392423469. Ann Oncol. 1998. PMID: 9739444 Free article.

3

Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial.

Biffi R, Orsi F, Pozzi S, Pace U, Bonomo G, Monfardini L, Della Vigna P, Rotmensz N, Radice D, Zampino MG, Fazio N, de Braud F, Andreoni B, Goldhirsch A. Biffi R, et al. Among authors: goldhirsch a. Ann Oncol. 2009 May;20(5):935-40. doi: 10.1093/annonc/mdn701. Epub 2009 Jan 29. Ann Oncol. 2009. PMID: 19179550 Free article. Clinical Trial.

4

Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter.

Mandalà M, Curigliano G, Bucciarelli P, Ferretti G, Mannucci PM, Colleoni M, Ventura A, Peruzzotti G, Severi G, Pelicci PG, Biffi R, Orsi F, Cinieri S, Goldhirsch A. Mandalà M, et al. Among authors: goldhirsch a. Ann Oncol. 2004 Apr;15(4):590-3. doi: 10.1093/annonc/mdh146. Ann Oncol. 2004. PMID: 15033664 Free article.

5

Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine.

De Pas T, de Braud F, Mandalà M, Curigliano G, Catania C, Ferretti G, Sozzi P, Solli P, Goldhirsch A. De Pas T, et al. Among authors: goldhirsch a. Lung Cancer. 2001 Feb-Mar;31(2-3):267-70. doi: 10.1016/s0169-5002(00)00176-8. Lung Cancer. 2001. PMID: 11165406 Clinical Trial.

6

Factors that predict early treatment failure for patients with locally advanced (T4) breast cancer.

Montagna E, Bagnardi V, Rotmensz N, Rodriguez J, Veronesi P, Luini A, Intra M, Scarano E, Cardillo A, Torrisi R, Viale G, Goldhirsch A, Colleoni M. Montagna E, et al. Among authors: goldhirsch a. Br J Cancer. 2008 Jun 3;98(11):1745-52. doi: 10.1038/sj.bjc.6604384. Epub 2008 May 27. Br J Cancer. 2008. PMID: 18506176 Free PMC article.

7

Institutional guidelines and ongoing studies in management of liver tumours: the experience of the European Institute of Oncology.

Biffi R, Orsi F, Zampino MG, Chiappa A, Fazio N, De Braud F, Bonomo G, Monfardini L, Vigna PD, Luca F, Bodei L, Bartolomei M, Catalano G, Leonardi MC, Ferrari M, Andreoni B, Goldhirsch A, Paganelli G, Orecchia R. Biffi R, et al. Among authors: goldhirsch a. Ecancermedicalscience. 2008;2:64. doi: 10.3332/eCMS.2008.64. Epub 2008 May 2. Ecancermedicalscience. 2008. PMID: 22275961 Free PMC article.

8

Preoperative versus postoperative docetaxel-cisplatin-fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 phase III trial.

Fazio N, Biffi R, Maibach R, Hayoz S, Thierstein S, Brauchli P, Bernhard J, Stupp R, Andreoni B, Renne G, Crosta C, Morant R, Chiappa A, Luca F, Zampino MG, Huber O, Goldhirsch A, de Braud F, Roth AD; Swiss Group for Clinical Cancer Research SAKK; European Institute of Oncology, Milan, Italy. Fazio N, et al. Among authors: goldhirsch a. Ann Oncol. 2016 Apr;27(4):668-73. doi: 10.1093/annonc/mdv620. Epub 2015 Dec 27. Ann Oncol. 2016. PMID: 26712905 Free article. Clinical Trial.

9

Axillary lymph node involvement in women with breast cancer: does it depend on age?

Botteri E, Bagnardi V, Goldhirsch A, Viale G, Rotmensz N. Botteri E, et al. Among authors: goldhirsch a. Clin Breast Cancer. 2010 Aug 1;10(4):318-21. doi: 10.3816/CBC.2010.n.042. Clin Breast Cancer. 2010. PMID: 20705566

10

Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden.

Nolè F, de Braud F, Aapro M, Minchella I, De Pas TM, Zampino MG, Monti S, Andreoni G, Goldhirsch A. Nolè F, et al. Among authors: goldhirsch a. Ann Oncol. 1997 Sep;8(9):865-70. doi: 10.1023/a:1008209429204. Ann Oncol. 1997. PMID: 9358936 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

719 results

Search Page

Filters